Completed
Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
NCT03556592
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- LEO Pharma Investigational Site Little Rock, Arkansas, United States
- LEO Pharma Investigational Site Rogers, Arkansas, United States
- LEO Pharma Investigational Site San Diego, California, United States
- LEO Pharma Investigational Site Doral, Florida, United States